Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

M Cella, M Salio, Y Sakakibara, H Langen, I Julkunen, A Lanzavecchia, M Cella, M Salio, Y Sakakibara, H Langen, I Julkunen, A Lanzavecchia

Abstract

The initiation of an immune response is critically dependent on the activation of dendritic cells (DCs). This process is triggered by surface receptors specific for inflammatory cytokines or for conserved patterns characteristic of infectious agents. Here we show that human DCs are activated by influenza virus infection and by double-stranded (ds)RNA. This activation results not only in increased antigen presentation and T cell stimulatory capacity, but also in resistance to the cytopathic effect of the virus, mediated by the production of type I interferon, and upregulation of MxA. Because dsRNA stimulates both maturation and resistance, DCs can serve as altruistic antigen-presenting cells capable of sustaining viral antigen production while acquiring the capacity to trigger naive T cells and drive polarized T helper cell type 1 responses.

Figures

Figure 1
Figure 1
Susceptibility to influenza virus infection of DC populations. (A and B) Percentage of DCs expressing viral proteins at high levels (A) or high plus low levels (B) 14 h after infection with different doses of PR8; immature DCs (▪), TNF-α–matured DCs (▵), LPS-matured DCs (⋄), IFN-α–treated DCs (○). The proportion of DCs expressing viral proteins and the level of expression were comparable when measured at 40 h (data not shown). (C and D) Level of expression of viral protein in DCs infected with PR8 at 5 HAU/ml (C) or 0.1 HAU/ml (D). The DCs were either untreated (1) or pretreated for 30 h with TNF-α (2), LPS (3), or IFN-α (4). Second antibody control (0).
Figure 2
Figure 2
LPS-matured DCs express MxA protein and are more resistant than immature DCs to the cytopathic effect of influenza virus at high MOI. Immature DCs were left untreated (A and H) or were infected with PR8 at 1 HAU/ml (B and I), 10 HAU/ml (C and L) or 30 HAU/ ml (D and M). Mature DCs (40 h after LPS) were left untreated (E and N) or were infected with PR8 at 10 HAU/ml (F and O) or 100 HAU/ml (G and P). After 24 h the cells were tested for the expression of MxA and influenza HA proteins (A–G). Viable, early and late apoptotic cells were evaluated in the same samples by staining with FITC-labeled Annexin V and propidium iodide (H–P).
Figure 3
Figure 3
MxA expression is rapidly induced in DCs by LPS, poly I:C and viral infection. Time course of MxA upregulation as detected by intracellular staining (A) or immunoblotting (B). (C) Time course of type I IFN production in culture supernatant. DCs were stimulated with the following: 50 U/ml IFN-α (○, panel A only), LPS (▵), 20 μg/ml poly I:C (▪), 1 HAU PR8 (•), TNF-α (▿), and CD40L (⋄). (D) MxA induction after 5 h of stimulation in the absence (black bar) or in the presence of two neutralizing sheep antisera to human type I IFN: Iivari, hatched bars, and Kaaleppi, empty bars.
Figure 4
Figure 4
dsRNA and PR8 infection induce upregulation of total protein and HLA class I synthesis in untreated as well as in IFN-α–pretreated DCs. Total protein synthesis (hatched bars) and HLA class I synthesis (black bars) were measured in DCs (A and C) or Hela cells (B and D) 5 h after stimulation with 20 μg/ml poly I:C, 5 HAU PR8, or medium alone. The cells were either untreated (A and B) or pretreated for 24 h with 500 U/ml IFN-α (C and D).
Figure 5
Figure 5
Increase in MHC class I biosynthesis and stability induced by PR8 infection allows efficient presentation of viral antigen to cytotoxic T cells. (A) Synthetic rate and stability of HLA class I molecules in immature DCs and in DCs that were stimulated for 5 h with 5 HAU/ml PR8 or LPS. Labeled class I molecules were precipitated after 1 h of chase (time 0) or after 12 or 24 h. (B) Half-life of labeled HLA class I molecules quantitated by PhosphorImager in immature DCs (○), LPS-treated DC (•), or PR8-infected DC (▴). (C) Proliferative response of an HLA-A2– restricted M58-66–specific T cell clone cultured with graded numbers of HLA-A2+ DCs. DCs were either pulsed with 1 μM M58-66 peptide (circles) or infected with 5 HAU/ml PR8 with (triangles) or without (squares) IFN-α (500 U/ml) pretreatment. DCs were tested 5 h (open symbols) or 24 h after pulsing (filled symbols).
Figure 6
Figure 6
PR8 infection and poly I:C increase the T cell stimulatory capacity of DCs. Proliferative response of cord blood naive T cells stimulated with graded numbers of irradiated allogeneic DCs. DCs were untreated (•) or pretreated for 24 h with 50 U/ml IFN-α (×), LPS (⋄), TNF-α (▵), or 20 μg/ml poly I:C (□), or infected with 3 HAU/ml PR8 (○).
Figure 7
Figure 7
Poly I:C primes for a Th1 response. IFN-γ and IL-4 production by polyclonal T cell lines generated by stimulating purified CD45RA+CD4+ T cells with allogeneic DCs. A, TNF-α–matured DCs; B, poly I:C-matured DCs; C, poly I:C-matured DCs in the presence of neutralizing antibodies to IL-12. A strong Th1 response was also obtained with LPS-matured DCs (data not shown). In some experiments both anti–IL-12 and anti–IFN-α antibodies were required to inhibit Th1 development. Anti–IL-12 antibodies did not affect polarization induced by TNF-α–matured or immature DCs.

References

    1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245–252.
    1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271–296.
    1. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med. 1994;179:1109–1118.
    1. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995;182:389–400.
    1. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 1997;388:782–787.
    1. Pierre P, Turley SJ, Gatti E, Hull M, Meltzer J, Mirza A, Inaba K, Steinman RM, Mellman I. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature. 1997;388:787–792.
    1. Braciale TJ, Yap KL. Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells. J Exp Med. 1978;147:1236–1252.
    1. Yewdell JW, Bennink JR, Hosaka Y. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science. 1988;239:637–640.
    1. Townsend AR, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 1986;44:959–968.
    1. Gotch F, Rothbard J, Howland K, Townsend A, McMichael A. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature. 1987;326:881–882.
    1. Bhardwaj N, Bender A, Gonzalez N, Bui LK, Garrett MC, Steinman RM. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+T cells. J Clin Invest. 1994;94:797–807.
    1. Bender A, Albert M, Reddy A, Feldman M, Sauter B, Kaplan G, Hellman W, Bhardwaj N. The distinctive features of influenza virus infection of dendritic cells. Immunobiology. 1998;198:552–567.
    1. Bender A, Bui LK, Feldman MA, Larsson M, Bhardwaj N. Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+cytolytic T cell responses. J Exp Med. 1995;182:1663–1671.
    1. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 1998;392:86–89.
    1. Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4 T helper and a T killer cell. Nature. 1998;393:474–478.
    1. Mogensen KE, Pyhala L, Cantell K. Raising antibodies to human leukocyte interferon. Acta Pathol Microbiol Scand Suppl. 1995;83:443–448.
    1. Ronni T, Melen K, Malygin A, Julkunen I. Control of IFN-inducible MxA gene expression in human cells. J Immunol. 1993;150:1715–1726.
    1. Caton AJ, Swartzentruber JR, Kuhl AL, Carding SR, Stark SE. Activation and negative selection of functionally distinct subsets of antibody-secreting cells by influenza hemagglutinin as a viral and a neo-self-antigen. J Exp Med. 1996;183:13–26.
    1. Cella M, Scheidegger D, Palmer K, Lehmann, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin 12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med. 1996;184:747–752.
    1. Nederman T, Karlstrom E, Sjodin L. An in vitro bioassay for quantitation of human interferons by measurements of antiproliferative activity on a continuous human lymphoma cell line. Biologicals. 1990;18:29–34.
    1. Valitutti S, Mueller S, Dessing M, Lanzavecchia A. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med. 1996;183:1917–1921.
    1. Pavlovic J, Arzet HA, Hefti HP, Frese M, Rost D, Ernst B, Kolb E, Staeheli P, Haller O. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J Virol. 1995;69:4506–4510.
    1. Pavlovic J, Haller O, Staeheli P. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J Virol. 1992;66:2564–2569.
    1. Meurs E, Chong K, Galabru J, Thomas NS, Kerr IM, Williams BR, Hovanessian AG. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell. 1990;62:379–390.
    1. Kumar A, Haque J, Lacoste J, Hiscott J, Williams BR. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci USA. 1994;91:6288–6292.
    1. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 1998;8:275–283.
    1. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods. 1996;196:121–135.
    1. Field AK, Tytell AA, Lampson GP, Hilleman MR. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci USA. 1967;58:1004–1010.
    1. Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Annu Rev Biochem. 1987;56:727–777.
    1. Manetti R, Annunziato F, Tomasevic L, Gianno V, Parronchi P, Romagnani S, Maggi E. Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. Eur J Immunol. 1995;25:2656–2660.
    1. van den Broek MF, Muller U, Huang S, Aguet M, Zinkernagel RM. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol. 1995;69:4792–4796.
    1. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 1994;264:1918–1921.
    1. Perussia B, Fanning V, Trinchieri G. A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. Nat Immun Cell Growth Regul. 1985;4:120–137.
    1. Pavlovic J, Zurcher T, Haller O, Staeheli P. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol. 1990;64:3370–3375.
    1. Ronni T, Sareneva T, Pirhonen J, Julkunen I. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J Immunol. 1995;154:2764–2774.
    1. Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, Trapani J, Cebon J. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol. 1998;161:1947–1953.
    1. Yang YL, Reis LF, Pavlovic J, Aguzzi A, Schafer R, Kumar A, Williams BR, Aguet M, Weissmann C. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO (Eur Mol Biol Organ) J. 1995;14:6095–6106.
    1. Medzhitov R, Janeway CA., Jr Innate immunity: the virtues of a nonclonal system of recognition. Cell. 1997;91:295–298.
    1. Kitajewski J, Schneider RJ, Safer B, Munemitsu SM, Samuel CE, Thimmappaya B, Shenk T. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell. 1986;45:195–200.
    1. Katze MG. Regulation of the interferon-induced PKR: can viruses cope? . Trends Microbiol. 1995;3:75–78.
    1. Jacobs BL, Langland JO. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology. 1996;219:339–349.
    1. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med. 1997;185:825–831.
    1. Kaser A, Molnar C, Tilg H. Differential regulation of interleukin 4 and interleukin 13 production by interferon alpha. Cytokine. 1998;10:75–81.

Source: PubMed

3
Se inscrever